Key Points
- CFO Jeffry Keyes sold 37,381 shares of Quantum‑Si on April 21 at an average price of $0.99 for about $37,007, reducing his stake by 2.11% to 1,732,582 shares valued at roughly $1.72 million.
- Quantum‑Si shares trade near $1 with weak fundamentals — a market cap of about $229 million, negative earnings (EPS -$0.08 last quarter) and low revenue — and analysts have a consensus "Hold" rating with an average price target of $3.25.
- Institutional activity is notable: several funds increased positions (Invesco up 177.7%, MIRAE asset increases) and Millennium Management opened a new ~$4.7 million stake, leaving institutions owning about 39.9% of the stock.
Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) CFO Jeffry Keyes sold 37,381 shares of the company's stock in a transaction that occurred on Tuesday, April 21st. The shares were sold at an average price of $0.99, for a total value of $37,007.19. Following the completion of the sale, the chief financial officer owned 1,732,582 shares in the company, valued at $1,715,256.18. The trade was a 2.11% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Quantum-Si Price Performance
Shares of QSI stock opened at $1.06 on Thursday. The business's 50 day simple moving average is $0.90 and its 200 day simple moving average is $1.28. Quantum-Si Incorporated has a one year low of $0.69 and a one year high of $3.10. The stock has a market capitalization of $229.35 million, a PE ratio of -2.04 and a beta of 3.08.
Quantum-Si (NASDAQ:QSI - Get Free Report) last issued its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.14) by $0.06. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%.The firm had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.76 million. As a group, research analysts expect that Quantum-Si Incorporated will post -0.5 earnings per share for the current year.
Institutional Trading of Quantum-Si
Several hedge funds have recently modified their holdings of QSI. Invesco Ltd. increased its stake in shares of Quantum-Si by 177.7% in the 1st quarter. Invesco Ltd. now owns 103,657 shares of the company's stock valued at $124,000 after acquiring an additional 66,336 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Quantum-Si by 23.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 70,552 shares of the company's stock valued at $85,000 after acquiring an additional 13,546 shares in the last quarter. Millennium Management LLC bought a new stake in shares of Quantum-Si in the 1st quarter valued at $4,721,000. JPMorgan Chase & Co. raised its stake in Quantum-Si by 15.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 66,656 shares of the company's stock worth $131,000 after buying an additional 9,005 shares during the period. Finally, Rhumbline Advisers raised its stake in Quantum-Si by 36.0% during the 2nd quarter. Rhumbline Advisers now owns 203,967 shares of the company's stock worth $400,000 after buying an additional 53,994 shares during the period. Institutional investors own 39.90% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on QSI shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of Quantum-Si in a report on Friday, March 27th. Canaccord Genuity Group decreased their price target on Quantum-Si from $1.50 to $1.00 and set a "hold" rating for the company in a report on Wednesday, March 4th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, Quantum-Si currently has a consensus rating of "Hold" and an average price target of $3.25.
Read Our Latest Stock Analysis on QSI
About Quantum-Si
(
Get Free Report)
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
